{'fraction_non_alphanumeric': 0.04250033873808771, 'fraction_numerical': 0.02461496770696897, 'mean_word_length': 4.7742860868431345, 'pattern_counts': {'":': 0, '<': 16, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Regulatory Protein ChuP Connects Heme and Siderophore-Mediated Iron Acquisition Systems Required for Chromobacterium violaceum Virulence

Chromobacterium violaceum is an environmental Gram-negative beta-proteobacterium that causes systemic infections in humans. C. violaceum uses siderophore-based iron acquisition systems to overcome the host-imposed iron limitation, but its capacity to use other iron sources is unknown. In this work, we characterized ChuPRSTUV as a heme utilization system employed by C. violaceum to explore an important iron reservoir in mammalian hosts, free heme and hemoproteins. We demonstrate that the chuPRSTUV genes comprise a Fur-repressed operon that is expressed under iron limitation. The chu operon potentially encodes a small regulatory protein (ChuP), an outer membrane TonB-dependent receptor (ChuR), a heme degradation enzyme (ChuS), and an inner membrane ABC transporter (ChuTUV). Our nutrition growth experiments using C. violaceum chu deletion mutants revealed that, with the exception of chuS, all genes of the chu operon are required for heme and hemoglobin utilization in C. violaceum. The mutant strains without chuP displayed increased siderophore halos on CAS plate assays. Significantly, we demonstrate that ChuP connects heme and siderophore utilization by acting as a positive regulator of chuR and vbuA, which encode the TonB-dependent receptors for the uptake of heme (ChuR) and the siderophore viobactin (VbuA). Our data favor a model of ChuP as a heme-binding post-transcriptional regulator. Moreover, our virulence data in a mice model of acute infection demonstrate that C. violaceum uses both heme and siderophore for iron acquisition during infection, with a preference for siderophores over the Chu heme utilization system.


INTRODUCTION
Iron is an essential micronutrient required as a cofactor of proteins involved in different cellular processes (Braun and Hantke, 2011;Palmer and Skaar, 2016). The ability to vary from soluble ferrous (Fe 2+ ) to insoluble ferric (Fe 3+ ) states confers iron its catalytic properties but can result in high toxicity and low bioavailability (Braun and Hantke, 2011;Huang and Wilks, 2017). As a metal essential for both hosts and pathogens, iron is at the center of an evolutionary battle (Skaar, 2010;Hood and Skaar, 2012;Parrow et al., 2013;Sheldon et al., 2016). Hosts restrict iron availability using iron-sequestering proteins like transferrin, lactoferrin, haptoglobin, hemopexin, and calprotectin, a process known as nutritional immunity (Hood and Skaar, 2012;Cassat and Skaar, 2013;Ganz and Nemeth, 2015). Conversely, pathogens subvert the host-imposed iron limitation by employing strategies such as the production, release, and uptake of low-molecular-weight iron chelators (siderophores such as enterobactin) and high-affinity heme-binding proteins (hemophores such as HasA) (Wandersman and Delepelaire, 2012;Runyen-Janecky, 2013;Contreras et al., 2014;Sheldon et al., 2016).
Heme is a tetrapyrrole that coordinates iron at its center as Fe 2+ (heme) or Fe 3+ (hemin). It is a cofactor of proteins like cytochromes and catalases. Therefore, almost every organism requires heme, which is obtained by synthesis and/or uptake from exogenous sources (Runyen-Janecky, 2013;Choby and Skaar, 2016). The greatest iron reservoir in mammals is the heme bound into hemoglobin found inside the erythrocytes. Many bacteria use heme and hemoproteins (e.g., hemoglobin) from the host as an iron source, and the preference for heme or siderophore as the main iron acquisition strategy varies according to the bacterium and the infection status (Runyen-Janecky, 2013;Choby and Skaar, 2016;Sheldon et al., 2016;Zygiel et al., 2021). Heme uptake/utilization systems have been described in several bacterial pathogens, including Pseudomonas aeruginosa (Has, Phu, and Hxu), Yersinia spp (Hem and Hmu), Escherichia coli (Chu), and Staphylococcus aureus (Isd). In Gram-negative bacteria, the import of heme involves highaffinity TonB-dependent receptors (TBDRs) in the outer membrane (e.g., PhuR) and ABC-type transport systems in the periplasm and inner membrane (e.g., PhuTUV) (Eakanunkul et al., 2005;Noinaj et al., 2010;Fournier et al., 2011;Choby and Skaar, 2016;Huang and Wilks, 2017;Klebba et al., 2021). Once in the cytosol, heme is degraded by canonical or non-canonical heme oxygenases, releasing iron and other compounds (Contreras et al., 2014;Lamattina et al., 2016).
Genes encoding heme uptake systems are under complex regulation. They are regulated by Fur, a metalloregulator that uses Fe 2+ as cofactor to repress the expression of iron uptake systems (da Silva Neto et al., 2009;Chandrangsu et al., 2017;Sarvan et al., 2018) and activated by heme-dependent regulatory systems, such as the extracytoplasmic function (ECF) sigma factor signaling cascade Has (Wandersman and Delepelaire, 2012;Huang and Wilks, 2017). Small proteins from the HemP/HmuP family have been described as required for heme utilization by regulating the expression of heme uptake genes. However, the proposed regulatory mechanisms are quite distinct.
Chromobacterium violaceum is a Gram-negative betaproteobacterium found in the water and soil of tropical and subtropical regions that causes opportunistic human infections with high mortality rates (Yang and Li, 2011;Kumar, 2012;Khalifa et al., 2015;Batista and da Silva Neto, 2017). An important virulence determinant in C. violaceum is the Cpi1/1a type III secretion system involved in hepatocyte invasion and innate immune system activation (Miki et al., 2010;Zhao et al., 2011;Maltez et al., 2015). Recently, we demonstrated that C. violaceum relies on the regulator Fur, two putative endogenous catecholatetype siderophores, and the siderophore-acquisition TBDRs CbuA and VbuA to overcome host-imposed iron limitation (Batista et al., 2019;Santos et al., 2020). However, C. violaceum mutants lacking siderophores had moderate attenuation in virulence in a mouse model of acute infection (Batista et al., 2019), suggesting that C. violaceum uses siderophore-independent mechanisms for iron acquisition during infection. In the current work, we demonstrate that an operon with six genes, here named chuPRSTUV (chuchromobacterium heme utilization), encodes a Fur-regulated heme uptake system (ChuRTUV) that is required for heme and hemoglobin utilization in C. violaceum. We also show that the small heme-binding protein ChuP is required for heme and siderophore-mediated iron acquisition by acting as a post-transcriptional activator of the TBDR genes chuR and vbuA. Furthermore, using in vivo virulence assays in mice, we demonstrate that these heme and siderophore-mediated iron uptake systems work together to help C. violaceum overcome iron limitation in the host.

Construction of C. violaceum Mutant and
Complemented Strains mutants derived from the wild-type C. violaceum ATCC 12472 strain, with the exception of the DcbaCEBADchuPRSTUV strain that was obtained using the DcbaCEBA mutant as background (Batista et al., 2019). The insertion mutants for the nonribosomal peptide synthetase (NRPS) genes cbaF and vbaF were obtained by a protocol based on a single recombination event (Batista et al., 2019). For genetic complementation, the chuP, chuR, chuS, chuTUV, and chuPRSTUV genes were amplified by PCR, cloned into the low-copy-number plasmid pMR20, and transferred to the mutant strains by conjugation. The primers used for cloning, sequencing, and mutant confirmation are listed in Supplementary Table 1.

MIC Assay
To achieve iron-limited conditions in M9CH for C. violaceum, we determined the minimal inhibitory concentration (MIC) of DP in this medium, as previously performed in LB medium (Batista et al., 2019). Wild-type C. violaceum overnight cultures were diluted to an optical density at 600 nm (OD 600 ) of 0.01 in M9CH, without or with DP (100 µM, 112.5 µM, 125 µM, 132.5 µM, and 150 µM), and grown under agitation (250 rpm) at 37°C. The MIC of 132.5 µM DP for the WT strain was established based on the turbidity of the cultures after 24 h cultivation.

Growth Curves
Growth curves were determined in M9CH without or with Hm. Overnight cultures of C. violaceum strains were diluted in 5 mL of M9CH to an OD 600 of 0.02. Then, a new dilution (1:2) was performed to achieve an OD 600 0.01 and the required concentrations of Hm in 200 µL final M9CH in 96-well plates. The plates were incubated at 37°C under moderate orbital agitation in SpectraMax i3 MiniMax Imaging Cytometer Broad-host-range low-copy vector containing oriT, Tet R (Roberts et al., 1996) pET15b Expression of proteins with N-terminal His-tag; Amp R Novagen pGEM-T easy Cloning plasmid; Amp R Promega pRKlacZ290 pRK2-derived vector with promoterless lacZ gene, Tet R (Gober and Shapiro, 1992) (Molecular Devices). The measurements of OD 600 were recorded every 15 minutes over 24 hours. The experiment was performed in three biological replicates.

Heme and Hemoglobin Nutrition Assay
The ability of C. violaceum to use Hm and Hb as iron sources was assessed using a nutrition assay (Balhesteros et al., 2017) with some modifications. C. violaceum overnight cultures in M9CH were diluted to an OD 600 of 1.0 in M9CH. Then, 25 µL of each dilution were embedded in 25 mL of iron-depleted M9CH 0.8% agar (containing 50 µM, 100 µM, 125 µM or 150 µM of DP). Paper discs were added onto the plate surface, and 10 µL aliquots of 100 µM Hm, 20 mM NaOH, 150 µM Hb, and 100 mM NaCl were applied to individual discs. After incubation for 16 h at 37°C, we inspected for growth halos that developed around the discs. The growth area was quantified using the Image J software and normalized by subtracting the disc areas. The experiment was performed in three biological replicates.

Cell Viability in the Presence of Heme
The toxic concentrations of Hm for C. violaceum were assessed by cell viability. Overnight cultures were diluted to an OD 600 of 0.01 in M9CH without or with Hm (30 µM, 600 µM, and 2000 µM), and grown under agitation (250 rpm) for 24 h at 37°C. Serial dilution in phosphate-buffered saline (PBS) was performed, and 10 µL were spotted onto M9CH plates. Hemin toxicity was determined based on the colony-forming units (CFU) displayed by the strains after incubation for 24 h at 37°C. These experiments were performed in three biological replicates.

Hemolysis Assay
The hemolytic activity was assessed in 5% (v/v) sheep-blood Mueller-Hinton agar plates. Five microliters of C. violaceum M9CH overnight cultures were spotted onto the plate. The hemolytic activity was detected by the lighter halos that developed due to erythrocyte lysis after incubation for 7 days at 37°C. The area of activity was quantified using the Image J software and normalized by subtracting the bacterial growth area. The experiment was performed in three biological replicates.

Siderophore Assay
Siderophores were detected by chrome azurol S (CAS) plate assay in modified peptone-sucrose agar (PSA-CAS) plates (Batista et al., 2019;Santos et al., 2020). Ten microliters of C. violaceum overnight cultures in M9CH were spotted onto the plate surface, and the siderophores were detected by the orange halos that developed after incubation for 24 hours at 37°C. The area of the halos was quantified using the Image J software and normalized by subtracting the bacterial growth area. The experiment was performed in three biological replicates.

Transcriptional lacZ Fusions and b-Galactosidase Assays
The upstream regions of genes of interest were amplified by PCR with specific primers (Supplementary Table 1) and cloned into the pGEM-T easy plasmid (Promega). After digestion with proper restriction enzymes (Supplementary Table 1), the inserts were subcloned into the pRKlacZ290 vector to generate transcriptional fusions to the lacZ gene. C. violaceum cultures harboring the reporter plasmids were grown until an OD 600 of 0.6 -0.8 in M9CH, and either untreated or treated with 100 µM Hm or 100 µM FeSO 4 for 2 h. For all expression assays, the M9CH medium was used as the iron-limited condition because we previously found that the expression of an iron-regulated gene was similarly high in M9CH or M9CH with DP (Santos et al., 2020). Bacterial cells were assayed for b-galactosidase activity as previously described (Santos et al., 2020). The experiment was performed in three biological replicates.

Co-Transcription by RT-PCR
The C. violaceum wild-type strain was grown in M9CH until an OD 600 of 1.0 -1.2. Total RNA was extracted using Trizol reagent (Invitrogen) and purified with Direct-zol ™ RNA Miniprep Plus (Zymo Research). RT-PCR was performed with the SuperScript III One-Step RT-PCR System with Platinum Taq High Fidelity DNA Polymerase (Invitrogen). One microgram of each RNA sample and specific primers (Supplementary Table 1) that amplify regions from chuP to chuR (439 bp), chuR to chuS (373 bp), and chuS to chuT (662 bp) were used in the reactions. PCRs using conventional Taq DNA polymerase, and the same sets of primers, were performed with genomic DNA (positive control) and RNA (negative control) as templates.

Gene Expression by RT-qPCR
The C. violaceum wild type, DchuP, and DchuP[chuP] strains were grown in M9CH until midlog growth phase, and the cultures were either untreated or treated with 100 µM Hm or 100 µM FeSO 4 for 2 h. Total RNA was extracted and purified as described above. Two micrograms of total RNA from each sample were converted to cDNA using the High-Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific). Genomic DNA contamination (for RNA) and reverse transcription efficiency (for cDNA) were checked by conventional PCR with the primers for the rpoH gene (Supplementary Table 1). Quantitative PCR (qPCR) reactions were performed using the PowerUp ™ SYBR ™ Green Master Mix (Thermo Fisher Scientific), the specific primers (Supplementary Table 1), and 0.5 µL of cDNA. The relative expression was calculated by the 2 -DDCt method (Livak and Schmittgen, 2001). Data from three biological replicates were normalized by an endogenous control (rpoH gene) and a reference condition (WT in M9CH 100 µM Hm). The treatment with Hm was used as a control based on the bgalactosidase assays that indicated an intermediate expression of the chu operon under this condition.

Expression and Purification of the Recombinant ChuP
The coding region of chuP was amplified by PCR (Supplementary Table 1) and cloned into the pET-15b plasmid ( Table 1). After induction in E. coli BL21(DE3) with 1 mM Isopropyl b-D-1thiogalactopyranoside (IPTG) for 2 h at 37°C, the His-ChuP protein was purified from the soluble extract by affinity chromatography in a Ni-NTA Superflow column (Qiagen). The elution fractions were evaluated using 18% SDS-PAGE. The aliquots containing the purified His-ChuP were concentrated using a VivaSpin 6 column (Sartorius), and desalted by gel filtration in PD-10 column (GE Healthcare) in storage buffer (100 mM NaH 2 PO 4 , 600 mM NaCl, 20% glycerol, pH 8) (Puri and O'Brian, 2006). The concentration of the His-ChuP protein was determined by measurement of OD at 280 nm and using its extinction coefficient calculated by the Protparam Tool (ExPASy) (http:// web.expasy.org/protparam).

Heme Binding Assay
The ability of the recombinant His-ChuP protein to interact with Hm was evaluated by spectrophotometry (Puri and O'Brian, 2006;Amarelle et al., 2016). The reactions were performed in interaction buffer (50 mM Na 2 H 2 PO 4 , 300 mM NaCl, 10% glycerol, pH 8) without (reference cuvette) or with 10 µM of His-ChuP (sample cuvette). Aliquots of Hm (0 to 30 µM) were added to both cuvettes. After incubation for 5 minutes at 25°C in the dark, the absorbance between the wavelengths 300 and 600 nm was measured with 10 nm increments on a SpectraMax i3 MiniMax Imaging Cytometer. The binding of ChuP to Hm was determined by the change in absorbance at 413 nm fit to one-site binding model non-linear regression on Graph Pad Prism 7.

Electrophoretic Mobility Shift Assay (EMSA)
DNA sequences upstream of chuP, chuR, and CV_2599 were amplified by PCR using the primers listed in Supplementary  Table 1. The DNA fragments were radiolabeled and used for interaction with His-ChuP following a previously described protocol (da Silva Neto et al., 2009;Previato-Mello et al., 2017), with the modification of adding the CV_2599 promoter fragment (negative control) in the same reaction.

Mouse Virulence Assays
Virulence assays were performed in a mouse intraperitoneal (i.p.) model of C. violaceum infection as previously established (Previato-Mello et al., 2017;Batista et al., 2019). Bacterial strains were diluted to an OD 600 of 0.01 and cultured in 5 mL LB for 20 h at 37°C. A dose of 10 6 CFU in PBS was injected into 6-week-old female BALB/c mice, and the animals were monitored for 7 days post-infection. To assess the bacterial burden in the liver and spleen, mice were infected as above and euthanized 20 h or 96 h post-infection (h.p.i.

Statistical Analysis
Data collected were employed for statistical analysis in GraphPad Prism version 7. For the column graphs, the normality test was performed using Shapiro-Wilk's test. Statistically significant p values and the tests that were performed are indicated in the figure legends.

RESULTS
The chuPRSTUV Operon Is Regulated by Fur According to the Iron Levels In silico analysis of the C. violaceum ATCC 12472 genome sequence revealed a gene cluster with six genes (CV_RS19275-280-285-290-295-300) that resembles an operon encoding a putative heme utilization system. These genes, here named chuPRSTUV, are annotated as a HemP/HmuP family regulator (ChuP), a TonB-dependent receptor (ChuR), a hemin degrading factor (ChuS), and an ABC-transport system (ChuTUV) ( Figure 1A). To evaluate if the chuPRSTUV genes are organized into an operon, we performed RT-PCR reactions using RNA from the WT strain grown in M9CH and a set of primers that amplify regions between chuPR, chuRS, and chuST genes ( Figures 1A, B). After reverse transcription and amplification, bands with the expected sizes were detected for the three tested primer combinations, confirming that the chuPRSTUV genes are indeed co-transcribed ( Figure 1B). Our inspection of the promoter region of chuP revealed a putative Fur binding site sequence (ATGATAATGGTTATCATT) that resembles Fur boxes found in other bacteria (Sarvan et al., 2018). To investigate whether the chu operon is regulated by iron and Fur, we cloned the promoter region of chuP into a lacZ reporter plasmid. The WT and Dfur strains harboring the pchuP-lacZ fusion were used to assess the chuP promoter activity by bgalactosidase assay in M9CH medium, which was previously reported as an iron-limited condition (Santos et al., 2020) and under iron sufficiency (M9CH supplemented with Hm or FeSO 4 ) ( Figure 1C). The promoter activity was higher under iron-limited (M9CH) than iron-replete conditions in the WT strain. The reduction in activity was higher with FeSO 4 than with Hm supplementation. In the Dfur mutant, the promoter was highly active regardless of iron levels. Moreover, the activity was twofold higher than that detected for the WT strain in M9CH, suggesting total promoter de-repression in the absence of Fur ( Figure 1C). Altogether, these results demonstrate that the chuPRSTUV genes comprise a Fur-repressed operon that is expressed under iron limitation.
The chuPRSTUV Operon Encodes a Heme Uptake System (ChuRTUV) and a Regulatory Protein (ChuP) Required for Heme and Hemoglobin Utilization To characterize the role of the chuPRSTUV operon in C. violaceum, we generated null-mutant strains deleted for single genes (DchuP, DchuR, and DchuS) or multiple genes (DchuTUV and DchuPRSTUV) of the chu operon, and their respective complemented strains. We also obtained a mutant strain lacking both the chu operon and the cbaCEBA genes (DcbaCEBADchuPRSTUV). The CbaCEBA enzymes are involved in the synthesis of 2'3-DHB, the precursor of  Figure 1).
To test the involvement of the C. violaceum chu genes in heme and hemoglobin utilization, we developed a nutrition assay providing 100 µM Hm or 150 µM Hb as alternative iron sources in M9CH medium chelated for iron with different DP concentrations (Supplementary Figure 2). We chose 125 µM DP to compare all strains ( Figure 2) because it was the best condition to visualize the growth halos in the WT strain (Supplementary Figure 2). Under these conditions (125 µM DP), the WT and the DchuS strains formed Hm and Hbstimulated growth halos. All the other mutant strains of the chuPRSTUV operon lost the ability to grow when Hm and Hb were provided as iron sources (Figure 2). For the DchuR strain, a very weak growth stimulus could still be detected only in the presence of heme ( Figure 2B). Genetic complementation of the mutant strains fully restored the growth in Hm and Hb under deficiency with 125 µM DP (Figure 2). The DcbaCEBA mutant that does not synthesize siderophores showed no growth halos at 125 µM DP (Figure 2), but its growth was clearly stimulated by Hm and Hb at 50 µM DP (Supplementary Figure 2). This is consistent with previous results indicating that the growth of a DcbaCEBA mutant is strongly impaired under DP-imposed iron limitation (Batista et al., 2019). Taken together, these results demonstrate that the chuPRSTUV operon encodes a heme uptake system (ChuRTUV) that is also involved in hemoglobin utilization. Moreover, the weak growth detected for the DchuR mutant with Hm but not with Hb suggests that C. violaceum has additional mechanisms in the outer membrane for heme uptake b u t r el i e s s p ec ifi c a l l y on Ch u R f or h e m e u p t a k e from hemoglobin.
Considering that the DchuS strain showed no altered phenotype for Hm and Hb utilization (Figure 2), we evaluated its role on cell viability under heme excess (Supplementary Figure 3). However, growth defects were not observed for the WT, DchuS, and all mutant strains even at a high Hm concentration of 2 mM, indicating that the chu operon has no role during our heme excess conditions. Interestingly, deletion of the chuPRSTUV operon in the DcbaCEBA mutant strain improved the small colony size phenotype ( Supplementary  Figure 3), previously described for this strain (Batista et al., 2019). We also tested the hemolytic activity of the chu mutants on sheep-blood agar (Supplementary Figure 4). The strains DchuR (increased and intense halo) and DcbaCEBA (intense halo) showed altered hemolytic activity when compared to that of the WT and the other mutant strains. Although the meaning of these findings is unclear, we speculate that the increased hemolytic activity in these strains is a compensatory mechanism to deal with iron/heme scarcity.

The DchuP Mutant Has Increased Siderophore Halos Due to Viobactin
To verify whether the chu operon affects the production/release of siderophores in C. violaceum, we tested the chu mutants on The RT-PCR reactions amplified fragments of 439 bp (Primers 1 and 2), 373 bp (Primers 3 and 4), and 662 bp (Primers 5 and 6). Conventional PCR was performed using genomic DNA (PCR) and RNA (NC) as controls. L, 1 Kb plus DNA Ladder (Thermo Scientific). (C) Promoter activity of the chu operon in response to iron and Fur. b-galactosidase assays were performed from the WT and Dfur strains harboring the chuP-lacZ fusion grown in M9CH medium and either untreated or treated with 100 mM Hm or 100 mM FeSO 4 . Data are from three biological replicates. ****p < 0.0001; ***p < 0.001; *p < 0.05; when not indicated, not significant. Two-way ANOVA followed by Dunnett's multiple-comparison test.
de Lima et al.

C. violaceum Heme Utilization System
PSA-CAS plates for siderophore detection as orange halos ( Figure 3) as previously described (Batista et al., 2019). The DchuP and DchuPRSTUV mutants showed increased siderophore halos, while the DchuR, DchuS, and DchuTUV mutants had siderophore halos similar to that of the WT strain ( Figures 3A, B). The DcbaCEBA strain showed no siderophore halo, as previously demonstrated (Batista et al., 2019), as well as the DcbaCEBADchuPRSTUV strain ( Figures 3A, B). After complementation, the siderophore halos were restored to WT levels in the DchuP[chuP] strain. For the strains DchuPRSTUV [chuPRSTUV] (almost absence of halo) and DcbaCEBA [cbaCEBA] (increased halo), the siderophore phenotypes reverted further on that observed in the WT strain ( Figures 3A, B), perhaps owing to overexpression of the genes into the plasmid. These data indicate that the small regulatory protein ChuP controls the siderophore levels in C. violaceum. C. violaceum produces the catecholate-type siderophores chromobactin and viobactin employing the NRPS enzymes CbaF and VbaF, respectively (Batista et al., 2019). We combined mutation in chuP with mutations in cbaF or vbaF to understand which siderophore contributes to the increased siderophore halos in DchuP. Individual deletion of cbaF or vbaF genes in the WT had no effect on siderophore halos ( Figures 3C, D), as previously reported (Batista et al., 2019). When these genes were deleted in the DchuP mutant background, a decrease in siderophore halos was observed in both cases. However, the halos were similar to that of the WT strain only when vbaF was deleted ( Figures 3C, D), demonstrating a prominent role of viobactin on the increased siderophore halos of DchuP. Altogether, these results suggest that ChuP controls the synthesis and/or uptake of the siderophore viobactin in C. violaceum.

ChuP Is a Heme-Binding Post-Transcriptional Regulator of chuR and vbuA Encoding TBDRs for Heme and the Siderophore Viobactin
Our data indicate that mutation of chuP in C. violaceum abolished heme utilization ( Figure 2) and altered the levels of the siderophore viobactin ( Figure 3). We employed different methodologies to elucidate how ChuP regulates these processes ( Figure 4). First, we tested whether ChuP is a heme-binding and Hb (C) was measured using Image J software by subtracting the area of the discs. Data are from three biological replicates. Mutant and complemented strains were compared to WT and WT[pMR20], respectively. ****p < 0.0001; when not indicated, not significant. One-way ANOVA followed by Tukey's multiplecomparison test.
de Lima et al.

C. violaceum Heme Utilization System
protein. We purified the recombinant protein His-ChuP and performed a heme-binding assay ( Figure 4A). After incubation with increasing Hm concentrations, a Soret peak at 413 nm was detected, indicating the formation of a ChuP-heme complex ( Figure 4A). The differential absorption spectroscopy at 413 was used to fit a single binding model and determined that ChuP binds heme with a k d = 18.36 ± 4.66 µM ( Figure 4A, insert). Considering that HemP/HmuP proteins have been described as transcriptional activators (Escamilla-Hernandez and O'Brian, 2012;Sato et al., 2017), we tested whether the C. violaceum ChuP regulates and binds into the intergenic regions upstream of chuP (promoter of the chu operon) and chuR ( Figures 4B, C). The WT and DchuP strains harboring these constructs (pchuP-lacZ or pchuR-lacZ) were assessed by b-galactosidase assay under different iron levels. The pchuP-lacZ promoter fusion was highly active under iron deficiency (M9CH) with a gradual decrease upon Hm and FeSO 4 supplementation ( Figure 4B), as previously observed in the WT strain ( Figure 1C). However, the same activity pattern was detected in the DchuP mutant strain, indicating that ChuP does not seem to regulate the promoter of the chu operon ( Figure 4B). The pchuR-lacZ fusion had no promoter activity regardless of the strain or condition, indicating the absence of a promoter upstream of chuR. Therefore, this fusion is not useful to verify the effect of ChuP on chuR expression. Consistent with the b-galactosidase assays, our EMSA assays indicated that ChuP does not bind to the probes containing only the promoter of the chu operon or containing the entire region from chuP to chuR ( Figure 4C). Altogether, these results demonstrate that ChuP does not regulate the promoter of the chu operon nor act as a DNA binding protein.
In E. meliloti, the HmuP protein activates the expression of the TBDR ShmR at a post-transcriptional level, probably by acting on a sequence HPRE (HmuP-responsive element). The HPRE sequences were predicted upstream of genes encoding heme TBDRs in many bacteria, including the C. violaceum chuR (sequence CCCGCAAGCCAGCCGACAGCCAGCCAGCG, -26 nt from the ATG start codon) (Amarelle et al., 2019). In addition to chuR, we found an HPRE sequence upstream of vbuA (sequence GCCAGCCAGACGACGCCGCCG, -49 nt from the ATG start codon), a TBDR gene located far from the chu operon ( Figures 4D, E), raising the possibility that ChuP is a posttranscriptional regulator in C. violaceum. To verify this hypothesis, we performed RT-qPCR for chuR, vbuA, and vbaF genes with RNA harvested from the WT, DchuP, and DchuP [pMR20], respectively. Insertion mutants (D) were compared to the strains they derived from. **p < 0.01; ***p < 0.001; ****p < 0.0001; when not indicated, not significant. Vertical asterisks indicate comparisons with the WT strain. One-way ANOVA followed by Tukey's multiple-comparison test.
de Lima et al.

C. violaceum Heme Utilization System
[chuP] under different iron levels ( Figures 4D-F). The expression of the three genes in the WT strain was high under iron-depleted and low under iron-sufficient conditions when compared to the control condition (WT grown in M9CH 100 µM Hm), as expected for genes related to iron acquisition ( Figures 4D-F). Consistent with our phenotypic results and the presence of HPRE elements, the expression of chuR and vbuA was decreased in the DchuP strain regardless of the iron levels ( Figures 4D, E), indicating that ChuP is a positive regulator required for the maximum expression of chuR and vbuA under iron limitation. Complementation of DchuP restored the expression of chuR and vbuA to the levels found in the WT strain ( Figures 4D, E). No differences in vbaF expression were detected between the WT and DchuP strains in any of the tested conditions ( Figure 4F), indicating that ChuP does not control the expression of VbaF, the NRPS for viobactin synthesis. Therefore, the decreased expression of chuR and vbuA in DchuP explains the inability of this mutant strain to use Hm and Hb (Figure 2) (via ChuR) and its increased siderophore halos (Figure 3) (inability to uptake viobactin via VbuA). The absorption spectra were measured from 300 nm to 600 nm on a SpectraMax i3 MiniMax Imaging Cytometer. The changes at 413 nm were used to calculate the ChuP-Hm affinity (insert). Data are shown as differential absorption spectra: the difference of values obtained from the sample cuvette (His-ChuP and Hm) against the reference cuvette (Hm). Data are from a single experiment of three independent replicates. L, protein ladder; E7 to E11, eluted fractions of purified ChuP. (B) ChuP does not regulate the promoter of the chu operon. The scheme (top) indicates the regions used for b-galactosidase or EMSA assays. b-galactosidase assays were performed from the WT and DchuP strains harboring chuP-lacZ and chuR-lacZ fusions grown in M9CH in the indicated conditions of iron availability. Data are from three biological replicates. **p < 0.01; ***p < 0.001; ****p < 0.0001. When not shown, n.s. (not significant). Two-way ANOVA followed by Dunnett's multiple-comparison test. (C) ChuP does not bind to DNA probes covering from chuP to chuR. The indicated concentrations of His-ChuP were used in EMSA assays with the chu indicated probes. In both cases, the promoter region of CV_2599 (control) was used as an in-reaction unspecific negative control. (D-F) chuR and vbuA but not vbaF have HPRE sequences and are regulated by ChuP. The predicted HPREs are indicated as colored bars in the gene maps. Expression was evaluated by RT-qPCR. cDNA was reverse transcribed from RNA obtained from the WT, DchuP, and DchuP[chuP] strains grown in M9CH, and either untreated or treated with 100 mM Hm or 100 mM FeSO 4 . Expression of chuR, vbuA, and vbaF is shown as the fold change relative to the control condition (WT in M9CH 100 mM Hm). Data are from three biological replicates. ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05; when not indicated, not significant. Vertical asterisks indicate comparisons with the WT strain at the same condition. One-way ANOVA followed by Tukey's multiple-comparison test.
de Lima et al.

C. violaceum Heme Utilization System
Indeed, a DvbuA mutant showed large siderophore halos (Batista et al., 2019) as those found in DchuP. Altogether, these results demonstrate that ChuP integrates the acquisition of heme and siderophore by acting as a heme-binding post-transcriptional regulator of the TBDR genes chuR and vbuA.

C. violaceum Employs Both Siderophores and Heme for Iron Acquisition During Infection
To assess the role of the heme utilization system ChuPRSTUV during C. violaceum infection, we performed mice virulence assays ( Figure 5). The animals were i.p. injected with a dose of 10 6 bacterial cells and analyzed for survival during seven days post-infection ( Figures 5A, B). The five null-mutant strains of the ChuPRSTUV system showed barely or no virulence attenuation compared to the C. violaceum WT strain ( Figure 5A). Previously, we determined that abrogating siderophore production in C. violaceum by deletion of the cbaCEBA genes causes moderate attenuation in virulence (Batista et al., 2019). Therefore, we checked whether heme and siderophores cooperate for virulence. Indeed, the DcbaCEBA strain showed an intermediate virulence attenuation, as expected, while a more expressive virulence attenuation was observed for the DcbaCEBADchuPRSTUV strain ( Figure 5A). Complementation of the latter strain with the chuPRSTUV operon reverted its virulence attenuation phenotype to the pattern observed for the DcbaCEBA mutant ( Figure 5B). We evaluated the bacterial burden in the liver and spleen, two organs colonized during C. violaceum infection that are involved in host heme recycling. Interestingly, the DcbaCEBADchuPRSTUV mutant displayed the same CFU counting as the WT strain at 20 hours post-infection in both organs ( Figures 5C, D). However, the bacterial burden was reduced (in the liver) and eliminated (in the spleen) at 96 hours post-infection ( Figures 5C, D). These results  infection (h.p.i.), the liver (C) and the spleen (D) were collected, homogenized, serially diluted, and plated for CFU quantification. *p < 0.05; **p < 0.01; when not indicated, not significant. One-way ANOVA followed by Tukey's (liver) or Dunnett's (spleen) multiple-comparison tests.
de Lima et al. C. violaceum Heme Utilization System indicate that the absence of siderophores and heme uptake does not impair initial colonization but impairs the bacterial maintenance in later infection stages. Altogether, these results indicate an interplay between the iron-acquisition strategies based on siderophore and heme during C. violaceum infection. In our acute infection model, the requirement of heme uptake for virulence becomes evident in the absence of siderophores.

DISCUSSION
In this work, we identified and characterized a heme and hemoglobin utilization system, here named ChuPRSTUV, which connects, via the regulatory protein ChuP, iron acquisition by heme and siderophore during C. violaceum infection ( Figure 6). Our data indicated that the genes chuPRSTUV compose an operon repressed by Fur under iron sufficiency. During iron limitation (as found inside the host), high expression of the chu operon (for heme uptake by the transport system ChuR-ChuTUV) and the vbaF and vbuA genes (for synthesis and uptake of the siderophore viobactin) occurred ( Figures 6A, B). Remarkably, we found that the maximum expression in iron scarcity of the TBDR genes chuR and vbuA depends on the small heme-binding protein ChuP. In our model, we propose that ChuP is a positive post-transcriptional regulator acting in the 5'-UTR of the chuR and vbuA transcripts ( Figure 6A). Without ChuP, the expression of chuR and vbuA dropped, rendering the DchuP mutant strain its inability to use Hm and Hb via ChuR and its increased siderophore halos (deficiency to uptake viobactin via VbuA). Moreover, our (B) Iron acquisition systems in C. violaceum for the uptake of heme (this work) and the siderophores viobactin and chromobactin (Batista et al., 2019). (C) Interplay between the uptake of heme and siderophore in the C. violaceum virulence. We propose that ChuP links heme and siderophore utilization by acting as a positive regulator of chuR and vbuA, which encode TBDRs for the uptake of heme (ChuR) and the siderophore viobactin (VbuA). In addition to Fur derepression, the expression of chuR and vbuA depends on ChuP under iron deficiency, possibly by a post-transcriptional mechanism involving HPRE (HmuP-responsive elements) sequences found in the 5'-UTR of the chuR and vbuA transcripts. In the absence of ChuP, the abundance of chuR and vbuA transcripts decreases, causing a reduction in heme and viobactin utilization. Different levels of virulence attenuation occurred when the ChuPRSTUV system (weak), the siderophores ( virulence data in mice demonstrated that C. violaceum uses both heme and siderophore for iron acquisition during infection, with a preference for siderophores over the Chu heme uptake system ( Figure 6C). We demonstrated that the chuPRSTUV genes are co-transcribed from an iron-responsive and Fur-repressed promoter in C. violaceum, a gene cluster organization and expression pattern that fit with those found for heme uptake system in other bacteria, such as B. multivorans, Yersinia spp., and P. aeruginosa (Sato et al., 2017;Si et al., 2017;Schwiesow et al., 2018;Otero-Asman et al., 2019). Our nutrition assays indicated that, with the exception of chuS, all genes of the chu operon are required for heme and hemoglobin utilization in C. violaceum, suggesting that ChuRTUV, composed by the TBDR ChuR and the ABC transport system ChuTUV, is a heme uptake system. This mechanism of heme import across the cell envelope is found in many Gram-negative bacteria (Stojiljkovic and Hantke, 1992;Burkhard and Wilks, 2007;Balhesteros et al., 2017;Huang and Wilks, 2017). The mutant DchuR but not the mutant DchuTUV showed a small halo of heme utilization, and both mutants were unable to use hemoglobin, suggesting that C. violaceum maybe have another TBDR for heme uptake but relies specifically on ChuR to obtain heme from hemoglobin. Indeed, in P. aeruginosa, a bacterium with three heme uptake systems (Phu, Has, and Hxu), the same ABC-transport system (PhuTUV) transfers heme to the cytosol after uptake by the TBDRs PhuR and HasR (Ochsner et al., 2000;Smith and Wilks, 2015;Otero-Asman et al., 2019). ChuR appears to act as a direct heme uptake transporter given that we do not find genes encoding hemophores in C. violaceum and ChuR does not have an N-terminal extension typically found in hemophore-based heme uptake systems (Biville et al., 2004;Wandersman and Delepelaire, 2012;Huang and Wilks, 2017). Since the C. violaceum DchuS mutant showed no phenotype under heme limitation or excess, further biochemical studies are necessary to investigate whether ChuS is a heme chaperone or a non-canonical heme oxygenase involved in heme degradation, as described in other bacteria (Suits et al., 2005;Amarelle et al., 2016;Lee et al., 2017).
Recent studies have shown regulatory and functional connections between heme and siderophores (Otero-Asman et al., 2019;Batko et al., 2021;Glanville et al., 2021;Zygiel et al., 2021). The increased siderophore halos detected in DchuP and DchuPRSTUV mutant strains indicate that chuP is the gene of the chu operon that connects heme and siderophore utilization in C. violaceum. ChuP belongs to the HemP/HmuP protein family, whose members are found in many proteobacteria (Amarelle et al., 2019). However, only HmuP from S. meliloti and B. japonicum and HemP from B. multivorans have been characterized. They are small regulatory proteins required for heme utilization by acting as positive regulators of heme-acquisition TBDR genes (Amarelle et al., 2010;Escamilla-Hernandez and O'Brian, 2012;Sato et al., 2017;Amarelle et al., 2019). In B. multivorans, a hmuP mutant showed decreased siderophore halos, but the underlying mechanism remains unexplored (Sato et al., 2017). Our data indicate that ChuP links heme and siderophore utilization by acting as a positive regulator required for the expression of chuR and vbuA, genes encoding the TBDRs used by C. violaceum for the uptake of heme/hemoglobin (ChuR) and the siderophore viobactin (VbuA) (Batista et al., 2019). Our data favor a working model of ChuP as a heme-binding post-transcriptional regulator acting in the 5'-UTR of the chuR and vbuA transcripts ( Figure 6). Supporting this model, we found that (i) ChuP of C. violaceum binds heme, as demonstrated for HmuP of B. multivorans (Sato et al., 2017); (ii) ChuP does not regulate the promoter of the chu operon (in front of chuP) and its effect on chuR does not occur at the transcriptional level since there is no promoter in front of chuR and ChuP does not bind to DNA probes covering the entire region from chuP to chuR; (iii) there is the presence, upstream of chuR and vbuA, of HPRE elements, which were described as conserved sequences probably acting on mRNA in the 5'-UTR of genes encoding heme-related TBDRs (Amarelle et al., 2019). Although HemP/HmuP proteins lack a typical DNA binding domain, they were described as direct DNA binding proteins in B. japonicum and B. multivorans, maybe by interacting with Irr and Fur (Escamilla-Hernandez and O'Brian, 2012;Sato et al., 2017). Our results suggest that ChuP in C. violaceum works similarly to HmuP in E. meliloti. However, it is necessary more work such as heme binding assays with detagged ChuP and mapping of the transcriptional start sites of chuR and vbuA to understand how ChuP binds heme and exerts its role as a post-transcriptional regulator on its target genes.
Several investigations have found that genes encoding heme uptake systems are upregulated in vivo (Cook et al., 2019;Rivera-Chavez and Mekalanos, 2019) and required for colonization and virulence of many bacterial pathogens (Skaar et al., 2004;Si et al., 2017;Abdelhamed et al., 2018;Cook et al., 2019;Rivera-Chavez and Mekalanos, 2019;Chatterjee et al., 2020). In many cases, bacteria explore multiple host iron sources, employing both heme and siderophore-based iron acquisition systems (Contreras et al., 2014;Huang and Wilks, 2017). Our prior work revealed that C. violaceum requires catecholate-type siderophores for virulence in mice (Batista et al., 2019). Our current findings based on the characterization of mutants without either siderophores, the chu operon, or both indicate that C. violaceum uses siderophores and heme but prioritizes siderophores over heme as an iron source during infection, at least in our mice model of acute systemic infection ( Figure 6C). In agreement with our data, a study that characterized mutants of multiple iron uptake systems showed a clear predominance of siderophores over heme transport systems in P. aeruginosa infecting lung (Minandri et al., 2016). However, the preference for a particular iron source changes according to its availability or the infection context. For instance, S. aureus prefers heme but uses siderophores when heme is scarce (Skaar et al., 2004); P. aeruginosa prioritizes siderophore systems in acute infections but switches to heme in long-term chronic infections (Marvig et al., 2014;Nguyen et al., 2014); and Vibrio cholerae relies on heme released by cholera toxin-dependent damage in the intestine (Rivera-Chavez and Mekalanos, 2019). Currently, we are developing a mouse model of abscess for C. violaceum infection. It will be interesting to investigate in this model whether C. violaceum alters its preference for siderophores and heme in log-term infections.

ETHICS STATEMENT
The animal study was reviewed and approved by Local Ethics Animal Committee (CEUA), Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.